A pair of recently-released studies shed new light on the staggering cost of developing new drugs an expense that now exceeds $2 billion per therapy on average.
Tony Danker, head of the Confederation of British Industry, in January warned the UK is at risk of squandering the vast economic opportunities available to nations investing in the energy transition. <b>Christophe Williams</b>, CEO of solar thermal company Naked Energy agrees, and here spells out some of the urgent actions Rishi Sunak's government must take to place solar thermal – and PV – at the heart of a green revolution.